Total Health

 

Total Health is the largest provider of free cancer care resources for people who are treating or living with cancer. Our programs arm cancer care teams with the latest research and strategies to improve patient outcomes.

For more info visit our website at Total Health.

 

San Juan
07:15

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on Rectal & Esophageal Cancer: What Are the OPRA, ECOG-ACRIN, and NRG/RTOG 1010 Trial Results? What Is the Efficacy of Trastuzumab/Trimodality Therapy for Esophageal Cancer?

FEATURING Kristina Mirabeau-Beale
  • 30 views
  • February 12, 2021
06:09

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HNSCCs: Is There a Favorable Safety Profile for Weekly CDDP + RT? Is a Lower RT Dose Efficient in the Postoperative Setting?

FEATURING Kristina Mirabeau-Beale
  • 29 views
  • February 12, 2021
09:51

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on the Pathways Heart Study: What Is the Risk of CVD in Women With and Without a History of Breast Cancer?

FEATURING Roohi Ismail-Khan
  • 15 views
  • February 11, 2021
10:26

2020 ASCO Virtual Direct™ Highlights

CV Complications in Cancer Patients: What Is the Impact of Cardiotoxicity on Patients and Survivors? Can Excercise Help With CV Morbidity During/After Chemotheraphy?

FEATURING Roohi Ismail-Khan
  • 14 views
  • February 11, 2021
08:27

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Review of Aggressive Local Therapy in MBC: Does Early Local Therapy Improve Survival? When to Consider LRD?

FEATURING Kristina Mirabeau-Beale
  • 87 views
  • February 11, 2021
  • 1
07:40

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Review of IO for Brain Mets in HER2+ MBC: What Is the Efficacy of Tucatinib Added to Trastuzumab & Capecitabine?

FEATURING Kristina Mirabeau-Beale
  • 8 views
  • February 11, 2021
06:31

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on Short Course RT for Rectal Cancer: What Are the RAPIDO Trial Outcomes? What Is the Survival Rate?

FEATURING Kristina Mirabeau-Beale
  • 58 views
  • February 11, 2021
04:44

2020 ASCO Virtual Direct™ Highlights

2020 ASCO PRODIGE 23 Trial Data on Advanced Rectal Cancer: TNT With mFOLFIRINOX vs. Preoperative Chemoradiation

FEATURING Kristina Mirabeau-Beale
  • 32 views
  • February 11, 2021
30:17

2020 ASCO Virtual Direct™ Highlights

ASCO Update on Payment Reform: Why Are Healthcare Costs Rising, and How to Enhance the Quality of Patient Care With New Models?

FEATURING Lee Schwartzberg, Ted Okon
  • 9 views
  • December 29, 2020
05:38

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced BC: Does Early Local Therapy Improve Survival in Patients With De Novo Metastatic Breast Cancer and an IPT?

FEATURING William Gradishar
  • 11 views
  • November 13, 2020
08:28

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced BC: Is Pembro + Chemo Effective in TNBC? Does Olaparib Monotherapy Show Activity in Disease With sBRCA1/2 or gPALB2 Mutations?

FEATURING William Gradishar
  • 108 views
  • November 13, 2020
09:08

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced ER+ BC: Does Palbociclib + Fulvestrant Improve PFS vs. Palbociclib + Letrozole? Is There a Benefit of PI3 Kinase Inhibitor Post-CDK4/6i?

FEATURING William Gradishar
  • 474 views
  • November 13, 2020
  • 1
09:02

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced HER2+ BC: Can Combination of Tucatinib/Trastuzumab/Capecitabine Become the SoC Among Patients With Brain Metastases?

FEATURING William Gradishar
  • 22 views
  • November 13, 2020
05:34

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on Relapsed DLBCL: Is Auto-HCT Beneficial in PET/CT+ Disease?

FEATURING Luis Fayad
  • 13 views
  • October 12, 2020
07:11

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on R/R iNHL: Does Axi-Cel Combination Offer Promising OS/PFS Results?

FEATURING Luis Fayad
  • 45 views
  • October 12, 2020
05:18

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Previously Untreated CLL: Does Time-Limited Triplet Therapy (BOVen) Result in Achieving uMRD?

FEATURING Luis Fayad
  • 129 views
  • October 12, 2020
  • 1
06:14

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on R/R cHL: Does Pembro Show Any PFS Improvement Compared to BV?

FEATURING Luis Fayad
  • 64 views
  • October 12, 2020
06:09

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Aggressive B-Cell Lymphomas: Can Venetoclax Work as Initial Therapy? Is AUTO3 CAR-T Agent Promising in DLBCL?

FEATURING Luis Fayad
  • 49 views
  • October 12, 2020
07:15

2020 ASCO Virtual Direct™ Highlights

2020 ASCCO Update on Cervical Cancer: What Is the Impact of Sentinel Node Sampling in Survival in Early Stage Disease?

FEATURING Ingrid Ramirez
  • 18 views
  • September 30, 2020
15:36

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Ovarian Cancer: Does Maintenance Olaparib Provide OS Improvement in Platinum-Sensitive, Relapsed Disease and BRCAm? What Is the Impact of Surgery in Recurrent Disease?

FEATURING Ingrid Ramirez
  • 60 views
  • September 30, 2020
36:52

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on CRC: Pembro vs. Chemo for MSI-H/dMMR Metastatic Colorectal Cancer - Are There Improvements in PFS and ORR?

FEATURING Christina Gomez
  • 32 views
  • September 16, 2020
08:49

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on mCRC: FDA Approved Encorafenib + Cetuximab Combination w/ or w/o Binimetinib for BRAF V600E mCRC - Which Option Has Better Overall Efficacy? Is This the New SoC?

FEATURING Christina Gomez
  • 90 views
  • September 16, 2020
07:19

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on HER2-Expressing mCRC: Was There Any Activity in HER2+ Patients Treated With T-DXd ADC?

FEATURING Christina Gomez
  • 134 views
  • September 16, 2020
  • 1
07:11

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Stage 3 Rectal Cancer: Can We Reduce Distant Metastases Without Increasing Local Failure? Are There Changes to Overall QoL With Short-Course RT Followed by Chemo Before TME?

FEATURING Christina Gomez
  • 318 views
  • September 16, 2020
19:57

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on GE Adenocarcinomas: How Does Neoadjuvant Trastuzumab Affect Treatment? Are there Improvements From the Addition of Tras+Pertuzumab?

FEATURING Daniel Catenacci
  • 183 views
  • September 16, 2020
  • 1
09:58

2020 ASCO Virtual Direct™ Highlights

Updates on Advanced GE Cancers: 2L FOLFIRI + Ramucirumab vs. Paclitaxel + Ramucirumab, T-DXd in HER2+Disease

FEATURING Daniel Catenacci
  • 394 views
  • September 16, 2020
05:59

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Pancreatic Cancer: Perioperative Chemo + mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel for PDAC - Which Option Improves Chemo Delivery and Early Control of Systemic Disease?

FEATURING Daniel Catenacci
  • 515 views
  • September 16, 2020
  • 1
33:37

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Breast MRI: Is MRI Important in Neoadjuvant Chemotherapy Decision Making?

FEATURING Eva Cruz Jove
  • 158 views
  • September 2, 2020
38:48

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Breast Cancer Update: Recent Surgical Advancements, COVID-19 Challenges & Future Directions

FEATURING Jane Mendez
  • 16 views
  • September 2, 2020
09:23

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Melanoma: Dabrafenib + Trametinib in Patients With Resected Stage III BRAF V600-Mutant Melanoma - Is There a Long-Term Survival Benefit?

FEATURING Omar Rashid
  • 59 views
  • September 13, 2020
12:26

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on Metastatic Mucosal Melanoma: How Promising Is Toripalimab + Axitinib?

FEATURING Omar Rashid
  • 41 views
  • September 16, 2020
07:40

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on High-Risk Stage III Melanoma: Pembro vs. Placebo - What Is the Incidence of irAEs?

FEATURING Omar Rashid
  • 117 views
  • September 10, 2020